Last reviewed · How we verify

NCT05647967

Features of Regional Perfusion of Lung Consolidation

Status unknown Last updated 13 December 2022
What this trial tests

trial testing Ultrasound in Lung Injury, Acute in 200 participants. Status unknown.

Timeline
1 January 2022
Primary endpoint
31 December 2023
31 January 2024

Quick facts

Lead sponsorPeking Union Medical College Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date1 January 2022
Primary completion31 December 2023
Estimated completion31 January 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking Union Medical College Hospital

Who can join

Adults 18 to 90, any sex, with Lung Injury, Acute or Ultrasound Therapy; Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the potential usefulness of lung ultrasound to assess the size and perfusion of consolidation and explore their relationships with clinical outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ultrasound

Trials testing the same drug.

Other recruiting trials for Lung Injury, Acute

Currently open trials in the same condition.

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05647967.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing